Ryall Scott, Guzman Miguel, Elbabaa Samer K, Luu Betty, Mack Stephen C, Zapotocky Michal, Taylor Michael D, Hawkins Cynthia, Ramaswamy Vijay
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
Pathology and Laboratory Medicine, Cardinal Glennon Children's Hospital, Pathology Department, Saint Louis University, Saint Louis, MO, USA.
Childs Nerv Syst. 2017 Jul;33(7):1047-1051. doi: 10.1007/s00381-017-3481-3. Epub 2017 Jun 16.
Mutations in the tail of histone H3 (K27M) are frequently found in pediatric midline high-grade glioma's but have rarely been reported in other malignancies. Recently, recurrent somatic nucleotide variants in histone H3 (H3 K27M) have been reported in group A posterior fossa ependymoma (EPN_PFA), an entity previously described to have no recurrent mutations. However, the true incidence of H3 K27M mutations in EPN_PFA is unknown.
In order to discern the frequency of K27M mutations in histone H3 in EPN_PFA, we analyzed 151 EPN_PFA previously profiled with genome-wide methylation arrays using a validated droplet digital PCR assay.
We identified only 1 case out of 151 EPN_PFA harboring the K27M mutation indicating that histone mutations are extremely rare in EPN_PFA. Morphologically, this single mutated case is clearly consistent with an ependymoma, and the presence of the K27M mutation was confirmed using immunohistochemistry.
K27M mutations are extremely rare in EPN_PFA. Routine evaluation of K27M mutations in EPN_PFA is of limited utility, and is unlikely to have any bearing on prognosis and/or future risk stratification.
组蛋白H3尾部(K27M)突变在儿童中线高级别胶质瘤中常见,但在其他恶性肿瘤中鲜有报道。最近,在A组后颅窝室管膜瘤(EPN_PFA)中报道了组蛋白H3(H3 K27M)的复发性体细胞核苷酸变异,而该实体之前被认为没有复发性突变。然而,EPN_PFA中H3 K27M突变的真实发生率尚不清楚。
为了确定EPN_PFA中组蛋白H3 K27M突变的频率,我们使用经过验证的液滴数字PCR检测方法,分析了151例之前通过全基因组甲基化阵列分析的EPN_PFA。
在151例EPN_PFA中,我们仅鉴定出1例携带K27M突变,这表明组蛋白突变在EPN_PFA中极为罕见。形态学上,这例单一的突变病例显然符合室管膜瘤的特征,并且通过免疫组化证实了K27M突变的存在。
K27M突变在EPN_PFA中极为罕见。对EPN_PFA进行K27M突变的常规评估效用有限,并且不太可能对预后和/或未来的风险分层产生任何影响。